Trial Spotlights U.S. Drug Safety Concerns at Compounding Pharmacies Trial Spotlights U.S. Drug Safety Concerns at Compounding Pharmacies

A top U.S. Food and Drug Administration official testified on Monday that the agency has concerns about drugs made by compounding pharmacies and still sees problems with them six years after a fungal meningitis outbreak tied to a Massachusetts pharmacy killed 76 people.Reuters Health Information (Source: Medscape Allergy Headlines)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2Kvko9j